CDCA4P4

Across TCGA pan-cancer cohorts, CDCA4P4 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated CDCA4P4 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CDCA4P4 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CDCA4P4 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

KIRC, SKCM, and CESC are the cancer types where CDCA4P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.916	0.829	.001	89	view →
SKCM	DFS	Tertile	II,III,IV	0.655	0.471	<.001	84	view →
CESC	OS	Tertile	All	0.669	0.849	.001	58	view →
HNSC	DFS	Tertile	IV	0.439	0.256	.004	57	view →
READ	DFS	Median	III,IV	0.282	0.831	<.001	47	view →
COAD	OS	Quartile	IV	0.897	0.124	.002	25	view →
DLBC	DFS	Median	III,IV	1.000	0.457	.003	24	view →
LUSC	OS	Tertile	III,IV	0.222	0.513	.006	20	view →
KIRP	DFS	Tertile	III,IV	0.205	0.801	.013	18	view →
UCS	OS	Median	All	0.809	0.563	.009	14	view →
UVM	DFS	Quartile	II,III,IV	0.365	0.644	.031	11	view →
MESO	DFS	Median	III,IV	0.210	0.626	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

CDCA4P4–KIRC (OS)

Open the KIRC breakdown →